Logo image of CAH

CARDINAL HEALTH INC (CAH) Stock Price, Forecast & Analysis

USA - New York Stock Exchange - NYSE:CAH - US14149Y1082 - Common Stock

198.18 USD
-0.14 (-0.07%)
Last: 12/12/2025, 8:17:24 PM
198.18 USD
0 (0%)
After Hours: 12/12/2025, 8:17:24 PM

CAH Key Statistics, Chart & Performance

Key Statistics
Market Cap47.09B
Revenue(TTM)234.31B
Net Income(TTM)1.59B
Shares237.60M
Float236.94M
52 Week High214.93
52 Week Low114.6
Yearly Dividend2.05
Dividend Yield1.03%
EPS(TTM)8.91
PE22.24
Fwd PE17.72
Earnings (Next)01-28 2026-01-28/bmo
IPO1983-08-04
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Providers & Services
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Distributors


CAH short term performance overview.The bars show the price performance of CAH in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 10 20 30

CAH long term performance overview.The bars show the price performance of CAH in the last 1, 2 and 3 years. 1 year 2 years 3 years 50 100 150

The current stock price of CAH is 198.18 USD. In the past month the price decreased by -3.82%. In the past year, price increased by 67.81%.

CARDINAL HEALTH INC / CAH Daily stock chart

CAH Latest News, Press Relases and Analysis

4 days ago - By: Zacks Investment Research
4 days ago - By: Zacks Investment Research - Mentions: AUPH
9 days ago - By: The Motley Fool - Mentions: CVX TGT
9 days ago - By: Zacks Investment Research - Mentions: CNMD
18 days ago - By: Zacks Investment Research

CAH Competitors/Peers

The largest stocks on the US markets in the "Health Care Distributors" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
MCK MCKESSON CORP 22.44 100.45B
COR CENCORA INC 21.64 67.12B
HSIC HENRY SCHEIN INC 15.88 9.01B
AHCO ADAPTHEALTH CORP 32.5 1.41B
OMI OWENS & MINOR INC 2.33 232.82M
WGRX WELLGISTICS HEALTH INC N/A 51.37M

About CAH

Company Profile

CAH logo image Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 57,700 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The firm also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The firm connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.

Company Info

CARDINAL HEALTH INC

7000 Cardinal Pl

Dublin Ohio OHIO 43017 US

CEO: Michael C. Kaufmann

Employees: 57700

CAH Company Website

CAH Investor Relations

Phone: 16147573033

CARDINAL HEALTH INC / CAH FAQ

Can you describe the business of CARDINAL HEALTH INC?

Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. The company is headquartered in Dublin Ohio, Ohio and currently employs 57,700 full-time employees. The firm is engaged in providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The firm also provides pharmaceuticals and medical products. The Company’s segments include Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution (GMPD). The Pharmaceutical and Specialty Solutions segment distributes branded and generic pharmaceuticals, specialty pharmaceuticals and over-the-counter healthcare and consumer products in the United States. Its GMPD segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The firm connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination.


Can you provide the latest stock price for CARDINAL HEALTH INC?

The current stock price of CAH is 198.18 USD. The price decreased by -0.07% in the last trading session.


Does CARDINAL HEALTH INC pay dividends?

CARDINAL HEALTH INC (CAH) has a dividend yield of 1.03%. The yearly dividend amount is currently 2.05.


What is the ChartMill technical and fundamental rating of CAH stock?

CAH has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


What is the expected growth for CAH stock?

The Revenue of CARDINAL HEALTH INC (CAH) is expected to grow by 15.07% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.


Can you provide the market cap for CARDINAL HEALTH INC?

CARDINAL HEALTH INC (CAH) has a market capitalization of 47.09B USD. This makes CAH a Large Cap stock.


What is the next earnings date for CAH stock?

CARDINAL HEALTH INC (CAH) will report earnings on 2026-01-28, before the market open.


CAH Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to CAH. When comparing the yearly performance of all stocks, CAH is one of the better performing stocks in the market, outperforming 92.94% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

CAH Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to CAH. Both the profitability and the financial health of CAH get a neutral evaluation. Nothing too spectacular is happening here.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

CAH Financial Highlights

Over the last trailing twelve months CAH reported a non-GAAP Earnings per Share(EPS) of 8.91. The EPS increased by 16.93% compared to the year before.


Industry RankSector Rank
PM (TTM) 0.68%
ROA 2.89%
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%35.64%
Sales Q2Q%22.44%
EPS 1Y (TTM)16.93%
Revenue 1Y (TTM)4.44%

CAH Forecast & Estimates

21 analysts have analysed CAH and the average price target is 216.79 USD. This implies a price increase of 9.39% is expected in the next year compared to the current price of 198.18.

For the next year, analysts expect an EPS growth of 20.46% and a revenue growth 15.07% for CAH


Analysts
Analysts81.9
Price Target216.79 (9.39%)
EPS Next Y20.46%
Revenue Next Year15.07%

CAH Ownership

Ownership
Inst Owners90.83%
Ins Owners0.22%
Short Float %3.4%
Short Ratio3.19